Related references
Note: Only part of the references are listed.A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance
Krishna Sriram et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
Cynthia Magro et al.
TRANSLATIONAL RESEARCH (2020)
COVID-19 cytokine storm: the interplay between inflammation and coagulation
Ricardo J. Jose et al.
LANCET RESPIRATORY MEDICINE (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
Thomas J. Oxley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Active thrombin produced by the intestinal epithelium controls mucosal biofilms
Jean-Paul Motta et al.
NATURE COMMUNICATIONS (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases
Jens J. Posma et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases
Dorothea M. Heuberger et al.
THROMBOSIS JOURNAL (2019)
Protease-activated receptor 1 inhibition protects mice against thrombin-dependent respiratory syncytial virus and human metapneumovirus infections
Vuong Ba Le et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Anticoagulant therapy in acute respiratory distress syndrome
Marta Camprubi-Rimblas et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Immunothrombosis in Acute Respiratory Distress Syndrome: Cross Talks between Inflammation and Coagulation
Frantzeska Frantzeskaki et al.
RESPIRATION (2017)
Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia
Yan Yang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Thrombin Increases Lung Fibroblast Survival while Promoting Alveolar Epithelial Cell Apoptosis via the Endoplasmic Reticulum Stress Marker, CCAAT Enhancer-Binding Homologous Protein
Ilia Atanelishvili et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Proteinase-activated receptors in fibroproliferative lung disease
Ricardo J. Jose et al.
THORAX (2014)
Thrombin induces epithelial-mesenchymal transition via PAR-1, PKC, and ERK1/2 pathways in A549 cells
Jeong Sup Song et al.
EXPERIMENTAL LUNG RESEARCH (2013)
PAR1 contributes to influenza A virus pathogenicity in mice
Khaled Khoufache et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
PAR-1 contributes to the innate immune response during viral infection
Silvio Antoniak et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Modulation of Protease Activated Receptor 1 Influences Human Metapneumovirus Disease Severity in a Mouse Model
Laetitia Aerts et al.
PLOS ONE (2013)
Pharmacokinetics of the novel PAR-1 antagonist vorapaxar in patients with hepatic impairment
Paul Statkevich et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
David A. Morrow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Concentration Dependent Dual Effect of Thrombin in Endothelial Cells Via Par-1 and Pi3 Kinase
Jong-Sup Bae et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells
T Suzuki et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation
OP Blanc-Brude et al.
EXPERIMENTAL CELL RESEARCH (2005)
Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells
N Asokananthan et al.
JOURNAL OF IMMUNOLOGY (2002)
Share Paper
